GlassScriptPhysician profile
Jack H Freimann
NPI 1306953021
$24,160.93
in general payments reported to CMS, 2019-2025
89 companies · $2,690 in 2025
The $2,690 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,979 · 2020: $2,846 · 2021: $3,456 · 2022: $4,119 · 2023: $4,769 · 2024: $3,302 · 2025: $2,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,174.21 |
| Education | $587.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,150.55 | 2019-2025 | |
| Pfizer INC. | $1,442.93 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,365.46 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $1,153.86 | 2019-2025 | Reblozyl, Pomalyst |
| Incyte Corporation | $1,020.53 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $918.16 | 2020-2024 | Tagrisso, Calquence, Imfinzi |
| Astellas Pharma US INC | $794.11 | 2019-2024 | Padcev |
| Janssen Biotech, INC. | $792.72 | 2019-2025 | Erleada, Darzalex, Rybrevant |
| Amgen INC. | $780.37 | 2019-2025 | Lumakras |
| Pharmacyclics LLC, An Abbvie Company | $734.59 | 2019-2023 | Imbruvica, Epkinly |
| Genzyme Corporation | $674.51 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $670.39 | 2019-2025 | Opdivo, Opdualag |
| Takeda Pharmaceuticals U.S.A., INC. | $662.92 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Exelixis INC. | $648.09 | 2019-2024 | Cabometyx |
| Gilead Sciences, INC. | $624.63 | 2019-2025 | Trodelvy |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $595.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $592.61 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Bayer Healthcare Pharmaceuticals INC. | $484.33 | 2019-2025 | |
| Abbvie INC. | $475.95 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $444.55 | 2020-2025 | Xpovio |
| Daiichi Sankyo INC. | $431.89 | 2019-2025 | Enhertu, Vanflyta |
| Lilly USA, LLC | $400.63 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Ipsen Biopharmaceuticals, INC | $387.70 | 2019-2025 | Onivyde, Somatuline Depot |
| Seagen INC. | $383.63 | 2019-2023 | Tukysa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.83 | 2019-2024 | Gilotrif |
| Genentech USA, INC. | $293.14 | 2019-2025 | Polivy, Phesgo |
| Puma Biotechnology, INC. | $285.32 | 2019-2025 | |
| Clovis Oncology, INC. | $242.68 | 2019-2020 | |
| Taiho Oncology, INC. | $235.17 | 2020-2024 | |
| Emd Serono, INC. | $233.50 | 2019-2024 | Bavencio |
| Array Biopharma INC | $229.78 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Regeneron Healthcare Solutions, INC. | $219.99 | 2021-2024 | Libtayo |
| Kite Pharma, INC. | $201.20 | 2021-2025 | Yescarta |
| Deciphera Pharmaceuticals INC. | $182.58 | 2021-2025 | Qinlock, Romvimza |
| Aveo Pharmaceuticals, INC. | $150.20 | 2021-2025 | Fotivda |
| Jazz Pharmaceuticals INC. | $144.67 | 2020-2025 | |
| Beigene USA, INC. | $134.60 | 2022-2024 | Brukinsa |
| Sobi, INC | $132.49 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $132.26 | 2019-2024 | Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $128.67 | 2019-2025 | Ultomiris |
| Stemline Therapeutics INC. | $119.12 | 2023-2025 | Orserdu |
| Blueprint Medicines Corporation | $109.16 | 2021-2025 | Ayvakit |
| Genmab U.S., INC. | $107.96 | 2023-2025 | Epkinly |
| Eusa Pharma (US) LLC | $96.31 | 2020-2022 | |
| Kyowa Kirin, INC. | $94.00 | 2020-2024 | Poteligeo |
| Servier Pharmaceuticals LLC | $85.46 | 2021-2024 | |
| Dova Pharmaceuticals | $84.17 | 2019-2021 | |
| Mirati Therapeutics, INC. | $83.37 | 2023-2024 | Krazati |
| Verastem, INC. | $82.15 | 2019-2020 | |
| Adc Therapeutics America, INC. | $66.63 | 2023-2025 | |
| Novocure INC. | $66.09 | 2022-2024 | Optune Lua (Novottf-200t), Optune |
| Beone Medicines USA, INC. | $65.76 | 2025 | Brukinsa |
| Coherus Oncology, INC. | $65.29 | 2024-2025 | Loqtorzi |
| Epizyme, INC. | $62.53 | 2020-2021 | |
| Foundation Medicine, INC. | $58.30 | 2020-2021 | |
| Immunogen, INC. | $52.75 | 2023 | Elahere |
| Springworks Therapeutics, INC. | $52.62 | 2025 | Ogsiveo |
| Secura Bio, INC. | $51.93 | 2019-2020 | |
| Tesaro, INC. | $49.43 | 2019 | |
| Tempus Ai, INC | $46.21 | 2024 | Xt Cdx |
| Pharmaessentia USA Corporation | $45.66 | 2023-2024 | Besremi |
| Morphosys, US INC. | $44.16 | 2021-2022 | |
| Emmaus Medical, INC. | $42.48 | 2021-2023 | Endari |
| Teva Pharmaceuticals USA, INC. | $42.22 | 2019 | |
| Agios Pharmaceuticals, INC. | $38.83 | 2020-2023 | Pyrukynd |
| Verity Pharmaceuticals INC. | $38.35 | 2023-2025 | Trelstar |
| Cumberland Pharmaceuticals, INC. | $33.66 | 2023 | Sancuso |
| Apellis Pharmaceuticals, INC. | $33.44 | 2025 | Empaveli |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Pharmacosmos Therapeutics INC. | $28.48 | 2023 | Monoferric |
| Adaptive Biotechnologies Corporation | $27.45 | 2022 | |
| Geron Corporation | $27.04 | 2025 | Rytelo |
| Aurobindo Pharma USA, INC. | $24.30 | 2019 | |
| Myovant Sciences INC. | $23.73 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $22.45 | 2019 | |
| G1 Therapeutics, INC. | $22.26 | 2022 | |
| Immunomedics, INC. | $21.48 | 2020 | |
| Recordati_rare_diseases_inc. | $20.77 | 2024 | Sylvant |
| Octapharma USA, INC. | $20.51 | 2022 | |
| Ge Healthcare | $20.32 | 2021 | |
| Csl Behring | $20.18 | 2019 | |
| Spectrum Pharmaceuticals INC. | $16.49 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.43 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.06 | 2021 | |
| Acceleron Pharma, INC. | $15.24 | 2021 | |
| Progenics Pharmaceuticals, INC. | $14.71 | 2024 | |
| Partner Therapeutics, INC. | $14.35 | 2019 | |
| Myriad Genetic Laboratories, INC. | $13.50 | 2021 | |
| Organon LLC | $8.08 | 2022 |
Drugs and devices associated with these payments
Keytruda $790Kisqali $714Reblozyl $343Onivyde $286Xtandi $252Enhertu $233Tukysa $224Elahere $217Lynparza $214Imbruvica $211Cabometyx $210Trodelvy $205Jakafi $193Lenvima $192Pomalyst $191Epkinly $184Ibrance $183Erleada $183Monjuvi $183Brukinsa $176Verzenio $174Jaypirca $174Ninlaro $173Talzenna $172Xpovio $166Libtayo $159Opdivo $154Jemperli $147Orgovyx $147Somatuline Depot $145Pemazyre $138Zejula $137Nubeqa $127Scemblix $127Adcetris $124Inlyta $122Mektovi $119Braftovi $119Orserdu $119Qinlock $118Fotivda $117Fruzaqla $112Vitrakvi $109Stivarga $109Bavencio $105Darzalex $101Inqovi $101Lonsurf $101Zepzelca $97.77Rybrevant $93.60Bosulif $92.45Tagrisso $90.35Talvey $87.89Tecvayli $87.89Welireg $86.37Elrexfio $86.14Alunbrig $84.66Krazati $83.37Enjaymo $82.70Ayvakit $82.46Rezlidhia $82.18Tavalisse $82.18Ultomiris $77.52Gilotrif $73.49Polivy $72.13Besponsa $71.27Calquence $70.51Lorbrena $70.51Sarclisa $67.18Padcev $58.48Doptelet $58.20Cablivi $55.62Imfinzi $55.34Pluvicto $54.36Ogsiveo $52.62Mekinist $51.10Vanflyta $50.91Ojjaara $48.69Besremi $45.66Romvimza $43.86Loqtorzi $43.39Iclusig $40.99Trelstar $38.35Promacta $36.71Optune Lua (Novottf-200t) $35.45Sancuso $33.66Empaveli $33.44Monoferric $28.48Paxlovid $28.37Nerlynx $28.03Akeega $27.71Rytelo $27.04Opdualag $26.83Xt Cdx $25.64Keytruda Qlex $25.61Phesgo $25.11Wayrilz $24.96Yescarta $24.66Lumakras $23.94Fabhalta $23.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Freimann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.